ArticlesRandomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
References (35)
Anticoagulants in the prevention of venous thromboembolism
Clin Haematol
(1990)- et al.
Venous thromboses and pulmonary embolisms in post-mortem series: probable causes by correlations of clinical data and basic diseases
Pathol Res Pract
(1994) - et al.
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction
Lancet
(1973) - et al.
Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke
Lancet
(1977) - et al.
Low dose heparin in the prevention of deep-vein thromboses in patients with acute myocardial infarction
Am Heart J
(1980) - et al.
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke
Lancet
(1987) - et al.
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
Lancet
(1992) - et al.
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery
N Engl J Med
(1988) Risk of and prophylaxis for venous thromboembolism in hospital patients
BMJ
(1992)Prevention of fatal pulmonary embolism
Haemostasis
(1993)
Low molecular weight heparin: a critical analysis of clinical trials
Pharmacol Rev
(1994)
Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?
J R Soc Med
(1989)
Incidence of venous thromboembolism verified by necropsy over 30 years
BMJ
(1991)
Pulmonary thromboembolism: clinicopathological correlations and multiple regression analysis of possible risk factors
Acta Chir Scand
(1977)
Some epidemiologic considerations of thromboembolism
Surg Gynecol Obstet
(1959)
Fatal pulmonary embolism in hospitalized non-surgical patients
Acta Med Scand
(1985)
Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction
N Engl J Med
(1973)
Cited by (235)
The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials
2023, International Journal of CardiologyAssociation between risk of venous thromboembolism and mortality in patients with COVID-19
2021, International Journal of Infectious DiseasesAmerican Society of Hematology 2021 guidelines for management of venous thromboembolism: Prevention and treatment in patients with cancer
2021, Blood AdvancesCitation Excerpt :We found 17 systematic reviews that addressed VTE prophylaxis for medically ill patients,60-76 with 24 studies in these reviews evaluating thromboprophylaxis vs no prophylaxis in acutely ill medical patients. All studies included hospitalized acutely ill medical inpatients but only a small proportion of patients had cancer.57,77-97 The panel also considered the RCT by Cohen et al57 (ARTEMIS) that compared fondaparinux against placebo and believed that the results were similar enough to include fondaparinux along with UFH and LMWH.
Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach
2021, Archivos de BronconeumologiaMortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis
2020, The Lancet Haematology
- 1
Members listed at end of article
Copyright © 1996 Published by Elsevier Ltd.